AVITA Medical (RCEL) Interest & Investment Income (2021)

AVITA Medical (RCEL) reported Interest & Investment Income of $45002.0 for Q2 2021.

AVITA Medical (RCEL) Interest & Investment Income (2021) Analysis & Trends

AVITA Medical has reported Interest & Investment Income for 1 years, with the latest figure at $45002.0 in Q2 2021.

  • For the quarter ending Q2 2021, Interest & Investment Income changed N/A year-over-year to $45002.0; the trailing twelve-month figure through Jun 2021 stood at $45002.0 (changed N/A YoY), and the FY2021 full-year result was $45002.0, changed N/A from the prior year.
  • Interest & Investment Income for Q2 2021 stood at $45002.0.
  • The five-year high for Interest & Investment Income was $45002.0 in Q2 2021, with the low at $45002.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 106.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 33.50 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 40.98 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 AVITA Medical 109.77 Mn 91.59 Mn 14.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 45,002.00